Intrapartum oxytocin: time to focus on longer term consequences?
- PMID: 31347150
- DOI: 10.1111/anae.14746
Intrapartum oxytocin: time to focus on longer term consequences?
Keywords: labour and delivery; oxytocic drugs; oxytocin; postpartum depression; postpartum haemorrhage; uterine atony.
Comment on
-
International consensus statement on the use of uterotonic agents during caesarean section.Anaesthesia. 2019 Oct;74(10):1305-1319. doi: 10.1111/anae.14757. Epub 2019 Jul 25. Anaesthesia. 2019. PMID: 31347151
References
-
- Weale N, Laxton C. Prophylactic use of oxytocin at caesarean section: where are the guidelines? Anaesthesia 2013; 68: 1006-9.
-
- Hua J, Chen G, Xing F, Scott M, Li Q. Effect of misoprostol versus oxytocin during caesarean section: a systematic review and meta-analysis. British Journal of Obstetrics and Gynaecology 2013; 120: 531-40.
-
- Su LL, Chong YS, Samuel M. Carbetocin for preventing postpartum haemorrhage. Cochrane Database of Systematic Reviews 2012; 4: CD005457.
-
- Pace NL, Stylianou MP. Advances in and limitations of up-and-down methodology: a précis of clinical use, study design, and dose estimation in anesthesia research. Anesthesiology 2007; 107: 144-52.
-
- Görges M, Zhou G, Brant R, Ansermino JM. Sequential allocation trial design in anesthesia: an introduction to methods, modeling, and clinical applications. Pediatric Anesthesia 2017; 27: 240-7.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources